Greater effect of stroke thrombolysis in the presence of arterial obstruction (Q35492120)

8 August 2017

title

Greater effect of stroke thrombolysis in the presence of arterial obstruction (English)

1 reference

8 August 2017

1 reference

Geoffrey A Donnan

13

0 references

Maarten G. Lansberg

object named as

Maarten G Lansberg

5

0 references

author name string

Deidre A De Silva

1

1 reference

8 August 2017

Leonid Churilov

2

1 reference

8 August 2017

Jean-Marc Olivot

3

1 reference

8 August 2017

Soren Christensen

4

1 reference

8 August 2017

Michael Mlynash

6

1 reference

8 August 2017

Bruce C V Campbell

7

1 reference

8 August 2017

Patricia Desmond

8

1 reference

8 August 2017

Matus Straka

9

1 reference

8 August 2017

Roland Bammer

10

1 reference

8 August 2017

Gregory W Albers

11

1 reference

8 August 2017

Stephen M Davis

12

1 reference

8 August 2017

EPITHET-DEFUSE Investigators

14

1 reference

8 August 2017

publication date

1 October 2011

1 reference

8 August 2017

1 reference

8 August 2017

volume

70

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

601-605

1 reference

Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study.

8 August 2017

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205432

Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study.

27 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205432

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

27 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205432

Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale.

27 July 2018

1 reference

Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET).

21 January 2018

1 reference

Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra

21 January 2018

1 reference

Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study

21 January 2018

1 reference

Relationship between magnetic resonance arterial patency and perfusion-diffusion mismatch in acute ischemic stroke and its potential clinical use.

21 January 2018

1 reference

Effect of Intravenous Thrombolysis on MRI Parameters and Functional Outcome in Acute Stroke <6 Hours

21 January 2018

1 reference

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

21 January 2018

1 reference

Acute ischemic stroke: predictive value of 2D phase-contrast MR angiography--serial study with combined diffusion and perfusion MR imaging

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22028220

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Vascular occlusion sites determine differences in lesion growth from early apparent diffusion coefficient lesion to final infarct

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22028220

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke: The DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke).

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22028220

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/ANA.22444

1 reference

8 August 2017

1 reference

8 August 2017

1 reference